Evaluate compliance with FDA Good Manufacturing Practice regulations for pharmaceutical and biotech manufacturing quality systems
QMS must include quality policy, procedures, and quality manual
21 CFR 211.22 requires independent quality oversight
Corrective and Preventive Action (CAPA) system required
Initial and ongoing GMP training required per 21 CFR 211.25
Health screening for communicable diseases and open lesions
21 CFR 211.42 facility design requirements
Temperature, humidity, and air quality monitoring required
Installation, Operational, Performance Qualification required
Cleaning validation prevents cross-contamination
21 CFR 211.84 requires identity testing at minimum
Quarantine until released by Quality Unit
Master Batch Records and executed Batch Records required
Critical parameters monitored and documented
Process validation per FDA guidance (lifecycle approach)
Identity, strength, quality, purity testing required
Accuracy, precision, specificity, LOD, LOQ validation
Ongoing stability to establish expiration dating
Please answer all required questions to see your results